184 related articles for article (PubMed ID: 6303581)
1. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
Wikstrand CJ; Bigner SH; Bigner DD
Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
[TBL] [Abstract][Full Text] [Related]
2. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
4. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
5. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.
Fargion S; Carney D; Mulshine J; Rosen S; Bunn P; Jewett P; Cuttitta F; Gazdar A; Minna J
Cancer Res; 1986 May; 46(5):2633-8. PubMed ID: 3008997
[TBL] [Abstract][Full Text] [Related]
7. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
8. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.
Bahler DW; Lord EM; Kennel SJ; Horan PK
Cancer Res; 1984 Aug; 44(8):3317-23. PubMed ID: 6378365
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
[TBL] [Abstract][Full Text] [Related]
12. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of human NK clones: target specificity and phenotype.
Allavena P; Ortaldo JR
J Immunol; 1984 May; 132(5):2363-9. PubMed ID: 6201541
[TBL] [Abstract][Full Text] [Related]
15. Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorometry analysis.
Cillo C; Mach JP; Schreyer M; Carrel S
Int J Cancer; 1984 Jul; 34(1):11-20. PubMed ID: 6746112
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG.
Wikstrand CJ; Bigner SH; Bigner DD
J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821
[TBL] [Abstract][Full Text] [Related]
18. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient.
Sugimoto T; Sawada T; Matsumura T; Kemshead JT; Ishii T; Horii Y; Morioka H; Morita M; Reynolds CP
Cancer Res; 1986 Sep; 46(9):4765-9. PubMed ID: 3731124
[TBL] [Abstract][Full Text] [Related]
19. Proportion of antigenic variants induced by in vitro UV irradiation differs in clones derived from a single tumor.
Hostetler LW; Kripke ML
J Immunol; 1988 Jan; 140(2):666-70. PubMed ID: 3335785
[TBL] [Abstract][Full Text] [Related]
20. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
